Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2024 Mar 12;18(3):e0011996. doi: 10.1371/journal.pntd.0011996

Factors related to willingness to participate in biomedical research on neglected tropical diseases: A systematic review

Vinícius Raimundo-Silva 1, Caio Torres Marques 1, João Rezende Fonseca 1, Martha Silvia Martínez-Silveira 2, Mitermayer Galvão Reis 1,2,3,*
Editor: Felix Bongomin4
PMCID: PMC10978008  PMID: 38470936

Abstract

Background

Understanding the barriers to and facilitators of participation in research could enhance recruitment rates for biomedical research on Neglected Tropical Diseases (NTDs) and help to avoid the problems associated with poor recruitment.

Methodology/principal findings

We conducted a systematic review to identify factors related to willingness to participate in biomedical research on Neglected Tropical Diseases (NTDs). Our search included the following databases: Medline/PubMed, Embase (Embase.com), Global Index Medicus (WHO), Web of Science (Core collection), and gray literature. We included studies that analyzed or reported factors associated with willingness to participate in NTD research, using either quantitative methods (such as clinical trials, cohorts, and cross-sectional studies) or qualitative methods (such as focus group discussions, semi-structured interviews, and in-depth interviews). There were no language restrictions, but we excluded review articles, notes, case reports, letters to the editor, editor’s notes, extended abstracts, proceedings, patents, editorials, and other editorial materials.

Screening of citations, data extraction, and risk of bias assessment was conducted by independent reviewers, according to the study protocol registered on PROSPERO. For analyses, we assessed the frequency of barriers, enablers, and the frequency of recruitment interventions mentioned in the included studies. The protocol for this systematic review was registered under registration number CRD42020212536. (S1 Appendix)

We identified 2070 citations, 1470 from the databases, and 600 from other sources. From those, eleven studies were selected for data extraction and analysis. The studies were conducted in Africa, Asia, and North America. Personal health benefits, monetary benefits, and community engagement and sensitization strategies were identified as the main reasons for participating in biomedical research on Neglected Tropical Diseases (NTDs). However, distrust in researchers, lack of knowledge about research methods among potential participants, and previous negative experiences were identified as the main barriers to participating in biomedical research on NTDs.

Conclusions/significance

This systematic review provides recommendations for improving adherence to biomedical research on Neglected Tropical Diseases, which can be applied in practice.

Author summary

Neglected Tropical Diseases (NTDs) are a group of around 25 health issues caused by different germs, and they bring about serious health, social, and economic problems. Those diseases mainly affect poor communities in tropical areas, and some are found in other regions too. Despite their big impact, NTDs don’t get much attention or funding from global agencies.

Studying NTDs is crucial to gather information that can help control and eliminate those diseases. However, there are challenges in doing this research, like having a hard time convincing enough people to participate. This is important to fix because if not enough people take part, the research results may not be reliable, and it can make the study take longer and cost more.

We did a careful review to understand what helps and what makes it challenging to convince people to participate in biomedical research on NTDs. Our findings can be useful for researchers to plan better, improve how many people take part in NTD studies, and avoid problems that come with not having enough participants.

Introduction

Since recruitment is an essential step in biomedical research involving human subjects, poor recruitment increases the possibility of the study being underpowered and introducing selection bias, which can lead to the overgeneralization of results [1,2]. Most studies fail to achieve their original recruitment rate, and around half of them need to extend the enrollment period. One of the main solutions to address poor recruitment is to extend the length of the research. However, this approach increases the cost and workload of the research team [3,4]. Researchers usually have to manage limited resources for their research, and having knowledge about facilitators and barriers of research, especially during the recruitment stage, can be helpful for better planning and overcoming challenges. In the past two decades, numerous studies have examined recruitment in various contexts [3,57], and have reported on barriers, motivations, and recruitment strategies that vary based on the research setting, methodology, and target population [8].

The World Health Organization (WHO) defines Neglected Tropical Diseases (NTDs) as a diverse group of communicable diseases that are prevalent in tropical and subtropical regions, affecting approximately one billion people and costing developing economies billions of dollars every year [9]. As of June 25th, 2020, WHO listed 20 diseases in its NTD portfolio [10]. Considering that NTDs are more prevalent in socioeconomically vulnerable communities, social determinants such as poverty, limited healthcare services, and illiteracy may limit the efficacy of recruitment [11].

In order to address the social and financial impacts caused by NTDs, public and private institutions have funded interventions aimed at controlling, eliminating, and eradicating those diseases [12]. Research plays a crucial role in providing evidence to improve interventions for preventing and treating NTDs. Research to identify etiological agents, disease management, and cost-benefit analysis is essential for defining what interventions should be implemented and what the likely impact would be in the contexts where they will be applied [13]. However, biomedical research involving human subjects, especially in the context of scarce resources, faces many barriers [5].

Research on NTDs has been underfunded, with only $100 million allocated in the United States in 2016, compared to $1.5 billion allocated to research on other diseases such as malaria, human immunodeficiency virus, and tuberculosis combined [14]. Since the recruitment problem directly impacts the research results and considering the scarce resources, it is necessary to study and better understand the reasons for this problem and the possible solutions. However, we did not find any systematic review that focuses specifically on the reasons why people refuse to participate in biomedical NTD research. Therefore, we conducted a systematic review to increase the understanding of the reasons for and against participating in biomedical research on NTD.

Methods

The protocol for this systematic review was registered in the PROSPERO database under registration number CRD42020212536. (S1 Appendix)

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were followed for reporting systematic reviews in this article. (S2 Appendix)

Search strategy and selection criteria

The inclusion criteria for this systematic review were studies that reported factors associated with willingness to participate in biomedical research on NTDs. The types of studies included were quantitative studies (e.g., clinical trials, cohorts, cross-sectional studies) and qualitative studies (e.g., focus group discussions, semi-structured interviews, and in-depth interviews). There were no language restrictions, but reviews, notes, case reports, letters to the editor, editor’s notes, extended abstracts, proceedings, patents, editorials, and other editorial materials were excluded. There was no restriction on the publication period of scientific publications.

The search strategy was based on four main steps that involved combining terms and subject headings and managing resources for the search strategy according to each database. The first step aimed to recover biomedical studies and other study designs for clinical research, while the second step recovered studies reporting community participation in research. The third step focused on studies reporting willingness or unwillingness to participate in research, and the fourth step aimed to recover studies on NTD, for which all terms related to the list of Neglected Tropical Diseases defined by the World Health Organization were included. In the final stage of the search strategy, the four steps were combined to obtain the final result. No limits or filter were used.

The searches in database were conducted by two researchers (MMS and VRS). We have chosen to utilize the following electronic databases: Medline via PubMed, Embase via Embase.com by Elsevier, Web of Science Core Collection via Clarivate Analytics and Global Index Medicus via World Health Organization (WHO) which is a platform that allows simultaneous searches in the following databases: African Index Medicus (AIM), Latin American and the Caribbean Literature on Health Science (LILACS), Western Pacific Region Index Medicus (WPRIM), Index Medicus for the Eastern Mediterranean Region (IMEMR), Index Medicus for the South-East Asian Region (IMSEAR). The PubMed search was conducted in July 2020, while the Embase, Global Index Medicus, and Web of Science searches were conducted in August 2020. In December 2020, a grey literature search was performed, and supplementary searches using the search strings "Willingness to participate in clinical trials" and "neglected tropical diseases" were conducted on Google Scholar. The first 100 results by relevance were selected and screened. After the screening step, a systematic citation search (“snowballing”) was conducted using the tool Connect Papers to collect all references cited in the included studies, as well as all citations received by them. All papers found were managed using the Mendeley software, which divided them according to the database they belonged to, removed duplicates (VRS) using Mendeley’s duplicate identification strategy, and then manually.

The reproducible search strategies for all databases are presented in Supporting Information. (S3 Appendix)

Studies selection

The scientific publications found after searching the indexed databases were screened in two stages: 1) eligibility criteria assessment through the review of titles and abstracts, and 2) eligibility criteria assessment through the full-text review. Both stages were conducted independently by two reviewers (JRF and VRS), and disagreements were resolved through discussion. The Mendeley software was employed for scientific publication selection.

Due to the time gap between the creation of the search strategy in 2020 and the commencement of writing this paper, we decided to update the search strategy in April 2023. We also reevaluated the study selection process with the aim of identifying articles published between August 2020 and April 2023. This step was conducted by a single reviewer, VRS.

Data collection

Data extraction from the papers was carried out by three independent reviewers (CTM, JRF, and VRS) to avoid perception bias, using Microsoft Excel software and Google Sheets programs. The following data were extracted: author name, year of publication, country, and continent where the research was conducted, NTD, study design, major study question, population, setting, nature of the study, and nationality of the corresponding author. The nature of the study was classified as hypothetical if subjects were asked about factors related to participation in hypothetical NTD biomedical research, retrospective if subjects who had been invited to participate in biomedical NTD research in the past were asked about factors related to research participation, and prospective if subjects were asked before being invited to participate in biomedical NTD research about factors related to research participation. The nationality of the corresponding author was included as a variable to assess whether the research leader was familiar with the environment where the willingness to participate was researched. Finally, barriers and facilitators for participation, and recruitment interventions reported in the studies were extracted. A guide was adopted with the meaning of each data category to enable data extraction and avoid discrepancies between reviewers.

Data analyses

We adapted the categories of reasons for participation and non-participation utilized by Browne et al [15]. We classified the enablers for participating into five categories: personal benefit, benefits for others, agreeable research aspects, social acceptance, and previous knowledge. We also classified the barriers to participating into five categories: physical harm, social harm, practical inconveniences, disagreement with research aspects, and personal opinions.

The four categories which we utilized to classify the recruitment interventions were adapted from UyBico et al 2007 [16] and are the following: community outreach, referrals, social marketing, and health systems.

In order to summarize results, we take into consideration the frequency of citation found in the qualitative included studies, while in included quantitative study, we considered the facilitators and barriers that were reported by the authors as statistically significant.

Quality assessment of included studies

Two reviewers (CTM and VRS) independently performed the assessment of the methodological quality of the included studies. Disagreements were resolved through discussion. For qualitative studies, we used the CASP Qualitative Studies Checklist. Whereas for cross-sectional studies, we used the Checklist for Analytical Cross-Sectional Studies.

Results

Search results

The search resulted in a total of 1470 citations, out of which only ten publications met the inclusion criteria and were included in the final review. One of the publications by Pérez-Guerra C et al [17]. included two studies, one taken in 2006 and the other in 2010. Those studies have different samples and report different enablers and barriers to participating in biomedical research. Therefore, we prefer to analyze them separately in our review. Fig 1 summarizes the study selection.

Fig 1. PRISMA flow diagram.

Fig 1

Study characteristics

Table 1 presents an overview of the included studies, which were published between 2009 and 2021. The majority of these studies were conducted in Africa (n = 8), followed by America (n = 2), and Asia (n = 1). Out of the 20 Neglected Tropical Diseases (NTDs) categorized by the WHO, the included studies focused on only five. Five studies investigated willingness to participate in research related to podoconiosis, three studies examined willingness to participate in dengue research, one study explored willingness to participate in schistosomiasis research, one study addressed willingness to participate in studies on onchocerciasis, and one study delved into willingness to participate in mycetoma research. Nearly all of the studies (n = 10) employed qualitative methods, with only one employing quantitative methods. The majority of the studies (n = 8) were carried out in rural areas, while the remainder were conducted in urban or peri-urban areas (n = 3). All of the studies had corresponding authors from the same countries where the studies were conducted. The majority of the studies (n = 8) had a nature prospective, while two had a nature hypothetical approach, and one employed a nature retrospective approach.

Table 1. Characteristics of included studies.

1 st author, year Country (Continent) Neglected Tropical Diseases Study design Major study question/First aim Study population Setting Nature of Study Nationality of the corresponding author
Pérez-Guerra C, 2012 (Study 1) [17] Puerto Rico (North America) Dengue Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) The objective of in-depth interviews (IDIs): to develop interview guide questions for focus-group discussions (FGDs): The objective of focus-group discussions (FGDs): to assess willingness to participate and let their children participate in a dengue vaccine trial in-depth interviews (IDIs): university research staff; focus-group discussions (FGDs): adults with laboratory-confirmed assessed dengue and adults with no history of dengue Urban Prospective Puerto Rican
Pérez-Guerra C, 2012 (Study 2) [17] Puerto Rico (North America) Dengue Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) The objective of in-depth interviews (IDIs): to assess knowledge about dengue and dengue prevention, the acceptability of having a dengue vaccine and willingness to support a dengue vaccine trial; The objective of focus-group discussions (FGDs): to identify knowledge, attitudes and beliefs toward vaccines and vaccine trials; determine parents’ willingness to allow children to participate in a dengue vaccine trial; and, identify common obstacles to recruitment in-depth interviews (IDIs): university researchers, mayors, school principals, school teachers, community leaders, parents belonging to community associations; focus-group discussions (FGDs): children aged 9–16 y with or without a history of confirmed dengue and their parents Urban Prospective Puerto Rican
Harapan H, 2016 [18] Indonesia (Asia) Dengue Quantitative research: cross-sectional To determine the factors that influence the willingness to participate in dengue research that would require phlebotomy procedures among participating healthy community members Healthy community members Urban Hypothetical Indonesian
Gebresilase T, 2017 [19] Ethiopia (Africa) Podoconiosis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) To explore barriers to getting genuine informed consent prior to enrolling participants in the genome-wide association study (GWAS) of podoconiosis in East Gojjam and East Wellega Zones of Ethiopia. in-depth interviews (IDIs): Healthy community members, podoconiosis patients, field workers, researchers, religious leaders, podoconiosis administrators, local leaders; focus-group discussions (FGDs): Healthy community members, podoconiosis patients Rural Prospective Ethiopian
Akun P, 2017 [20] Uganda (Africa) Onchocerciasis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) To build dialogue between communities and the research team, help the community understand research, encourage participation, the objectives and procedures of the study, and adherence to the study interventions and schedules. Healthy community members, health workers, and district leaders Rural Prospective Ugandan
Negussie H, 2016 [21] Ethiopia (Africa) Podoconiosis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) To explore optimal methods to provide information about the trial and approaches to the consent process preferred by the community. Overall, suggestions were grouped into five domains: approaching patients, information provision and comprehension, decision making, constraints to participation, and ways of explaining randomization and the control group. in-depth interviews (IDIs): researchers that conducted studies in the region, health professionals that work with filariasis, religious leaders, community leaders focus-group discussions (FGDs): community members with and without podoconiosis Rural Prospective Ethiopian
Sanya RE, 2017 [22] Uganda (Africa) Schistosomiasis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) To investigate the perceptions of six Lake Victoria island communities of Koome, Uganda, about interventions to control Schistosoma mansoni infection and their willingness to participate in Schistosoma vaccine trials. in-depth interviews (IDIs): community residents, community leaders, religious leaders, and health professionals. focus-group discussions (FGDs): community residents Rural Hypothetical Ugandan
Tekola F. 2009 [23] Ethiopia (Africa) Podoconiosis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) Were assessed determinants of and approaches to gaining informed consent for biomedical research in a predominantly rural Ethiopian population, and discuss the practical ways in which we used this information in a subsequent genetic study. in-depth interviews (IDIs): researchers, fieldworkers, community members, and local leaders; focus-group discussions (FGDs): community members Rural Prospective Ethiopian
Tekola F, 2009 [24] Ethiopia (Africa) Podoconiosis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) To explore the impact of social stigma on the process of obtaining consent for a study on the genetics of podoconiosis in Southern Ethiopia. in-depth interviews (IDIs) and focus-group discussions (FGDs): Scientist and researchers; Field workers; coordinators, leaders, Research knowledge and managers of the MFTPA (Mossy is feet treatment and prevention association); Administrative leaders; community leaders and community residents with and without podoconiosis Rural Prospective Ethiopian
Negash M, 2021 [25] Ethiopia (Africa) Podoconiosis Qualitative research: in-depth interviews (IDIs) and focus-group discussions (FGDs) Assess stakeholder perceptions of research, researchers and the informed consent pro- cess. in-depth interviews (IDIs):review board members; health extension workers and podoconiosis focal persons (health professionals managing podoconiosis patients); podoconiosis patients; healthy community members); kebele and local religious leaders; and researchers who witnessed youth protests and property damage at the study site in the 2018 incidents. focus-group discussions (FGDs): zonal and regional security officials from Bahir Dar and a second for health professionals who had experience of working with the community Rural Prospective Ethiopian
Omer R, 2021 [26] Sudan (Africa) Mycetoma Qualitative research: Report on challenges and barriers encountered in the research Report the challenges and barriers faced in the recruitment and retention of patients. Community residents, community leaders, religious leaders, and health professionals, staff of research Rural Retrospective Sudanese

Quality assessment of included studies

The ten qualitative studies were assessed based on nine quality criteria of CASP [27]. Each criterion was given either of the following three options “YES” if a criterion was met, or “CAN’T TELL” if the information present in the study is not enough to have a conclusion about the criteria, or “NO” if a criterion was not met. All studies (100%) were judged as having a clear statement of the aims of the research as well as having a qualitative methodology. Regarding the research design, six studies (54,5%) were judged as having an appropriate design to address the aims of the research, while there were also six studies (54,5%) judged as having a recruitment strategy appropriate to the aims of the research. Nine (81,8%) were judged as having collected the data in a way that addressed the research issue, however, only two studies (18,1%) were judged as having adequately considered the relationship between the researcher and participants. There were seven studies (63,6%) that considered ethical issues, eight studies (72,7%) were judged as having done sufficiently rigorous data analysis, and another seven studies (63,63%) were judged as having clear statement findings. Only one cross-sectional study was assessed based on the Checklist for Analytical Cross-Sectional Studies [28] and matched all quality criteria of this tool.

Factors favoring participation in biomedical research on NTD

In this step, we did not differentiate between qualitative and quantitative studies. Table 2 summarizes the reasons favoring participation in biomedical research on NTDs and citations. The frequency was calculated considering the number of studies out of a total of eleven that cited at least one specific reason for participating in research.

Table 2. Factors favoring participation in biomedical research on NTD.
Reasons category Frequency
Personal benefit
Personal health benefits : Possibility that the diseases are being addressed in the research. [17,19,23,24] (5/11)
Monetary benefit or other rewards : Participating in research is associated with receiving some kind of material or financial gain. [17,21,2325] (6/11)
Access to health care : Associated with free access to medical treatment. [17,19,26] (4/11)
Benefit for others
Altruism : The feeling of doing something good for the community. [17,23] (3/11)
Community involvement : Research brings benefits to the community of the potential participants. [21,24,26] (3/11)
Agreeable research aspects
Community strategies of engagement and sensibilization : Before starting the recruitment, the research staff did events to present the research to the community and tried to integrate the local community members into the research planning and execution. [1922,24] (5/11)
Comprehensive information for the study population : The research staff uses clear language that facilitates the comprehension of research by potential participants. [17,19,21,24,26] (5/11)
Written and oral Informed Consent Form : To avoid problems associated with illiteracy the informed consent form is obtained in written and oral aways. [19,24,25] (3/11)
Expenditure refund : The reimbursement for any research expenses is guaranteed for the potential participants. [17,26] (3/11)
Guarantee of confidentiality : The confidentiality of the information provided in the research is guaranteed. [19,22] (2/11)
Convenience (Logistic facility) : Taking part in the research doesn’t take much time and it’s accessible. [17] (1/11)
Positive previous experience : Potential participants had positive previous experiences with research. [19] (1/11)
Result Availability : Results are available at the end of the research. [19] (1/11)
Research attitude : There is a positive attitude by the researchers. [24] (1/11)
Social acceptance
Support from local leadership : Local leadership agrees with research and encourages the community members to participate in research. [19,21,24] (3/11)
To ensure time enough for discussion between community members and relatives : Community members have time enough for a collective debate about participating in research. [21,22,24] (3/11)
Integrate local community members in the research planning and execution: Self-explanatory. [19,21,25,26] (4/11)
Trust in researchers : Potential participants trust the researchers and their methods. [2325] (3/11)
Respect for the local values (cultural and religious): The research staff planned the research taking into account the local values (cultural and religious) of the research setting. [24] (1/11)
Previous knowledge
Knowledge about research : Potential participants have prior knowledge about research methods. [17,18] (3/11)
Education about the disease : Potential participants have prior knowledge about the disease covered by the research. [17,18] (3/11)
Attitudes about the disease : Potential participants have prior attitudes to avoid or prevent the disease covered by the research. [17,18] (2/11)

The most frequently cited reason favoring participation in biomedical research on NTDS was monetary benefits or other rewards, as reported by six studies. Additionally, personal health benefits, community engagement and sensitization strategies, and comprehensive information for the study population were each cited by five studies.

Factors serving as barriers to participation in biomedical research on NTD

Table 3 summarizes the denial of participation in biomedical research on NTD and citations. The frequency was calculated considering the number of studies out of a total of ten that cited at least one specific reason against participating in research.

Table 3. Factors serving as barriers to participation in biomedical research on NTD.
Reasons category Frequency
Physical harm
Safety concerns : Potential participants fear that the research will interfere with their health in some way. [17,23] (3/10)
Invasive procedures : The research methods include invasive procedures. [19,23,25] (3/10)
Worsening of the current medical condition : Self-explanatory. [17] (2/10)
Social harm
Cultural insensitivity : Some aspects of the research interfere with the participant’s cultural norms. [17,19,22,26] (4/10)
Lack of social support : People around the potential participants are not supportive of their participation in research. [17,21] (2/10)
Stigmatization : Been Identified as a subject of research causes social disapproval. [20,26] (2/10)
Confidentiality concerns : Potential participants fear that the confidentiality of their personal information will be violated. [22,25] (2/10)
Gender questions : The research procedures conflict with local gender questions (e. g some females were not comfortable being interviewed alone with a man from research). [19] (1/10)
Local political conflicts : Participating in research may be misconceived as a benefit for local politicians. [19] (1/10)
Religious belief: The research procedures conflict with the religious beliefs of potential participants. [23,26] (2/10)
Practical inconveniences
Inconvenience : Participating in research brings with it a lot of troubles. [17,21,26] (3/10)
The Large interval between sensibilization and recruitment : Self-explanatory. [21] (1/10)
Disagreement with research aspects
Mistrust : Distrust in the researchers. [17,19,2123] (6/10)
Insufficient compensation : Monetary or material compensation is not enough for the participant. [19,21,22] (3/10)
Lack of clarity : Potential participants did not understand aspects of the research that were not adequately explained. [19,23,24,26] (4/10)
Concerns with placebo: Potential participants are unwilling to receive a placebo. [17]] (2/10)
Disagreement with research requirement : Potential participants disagreed with the research objective, protocols, and procedures, and therefore refused to participate. [17,25,26] (2/10)
Communication problems between researchers and participants : The research staff uses a language that confuses the comprehension of research for potential participants. [19] (1/10)
Long studies (longitudinal): Potential participants consider the study duration long. [21] (1/10)
Personal opinions /Ignorance
Lack of knowledge: Potential participants have a lack of clear understanding of the research’s methods. [17,19,2123,25,26] (8/10)
Negative previous experiences : Potential participants had negative previous experiences with research. [17,19,20,24] (4/10)
“Therapeutic Misconception”: Potential participants confuse research objectives, protocols, and procedures with clinical treatment. [19,21,24,25] (4/10)
Not realizing the need to participate : Potential participants deny the necessity to participate in research. [19,22] (2/10)
Negative influence from media : Reports about research from media local resulted in an unwillingness to participate in research by potential participants. [17] (2/10)
False stories : Potential participants heard false stories about research. [21,25] (2/10)
Mistaken information about previous researches : Potential participants heard false stories about previous researches. [17] (1/10)

The most frequently cited reason serving as barriers to participation in biomedical research on NTDS was lack of knowledge, as reported by eight studies. Additionally, mistrust was cited by six studies.

We designed Fig 2 to make it more accessible for researchers to apply information on facilitators and barriers in the planning of studies on Neglected Tropical Diseases (NTDs). In this figure, we outline recommended actions and those to be avoided before and during the recruitment phase, as well as after the completion of the research.

Fig 2. Examples of potential solutions to improve recruitment rates.

Fig 2

Also see Tables 2 and 3 for other potential solutions. This Figure has been designed using images from ‘openclipart.org’.

Recruitment interventions

Table 4 summarizes the types of recruitment interventions and citations. The frequency was calculated considering the number of studies out of a total of seven that cited at least one type of recruitment intervention.

Table 4. Types of recruitment interventions.
Frequency
Community outreach
Contact with community leaders and organizations. [1921,24,26] (5/7)
Support from community health workers. [19,20,24,26] (4/7)
Face-to-face in the community setting. [17,20,21] (3/7)
Going to community houses with the support of local guides or people with influence in the community. [21,26] (2/7)
Lecture in community schools. [17,26] (2/7)
Presentations and meetings with community residents. [24,26] (2/7)
Referrals
Indication of friends and family. [19,21,22,26] (4/7)
Indication of other study participants. [19,21,22] (3/7)
Social marketing
Advertisement (Radio advertisements, Flyer, TV Advertisements, Newspaper advertisements, social media, instant messaging apps). [17,26] (3/7)
Health system
Recruitment in centers of care in health. [17,24,26] (3/7)

The most common recruitment intervention applied in biomedical research on NTDs was contact with community leaders and organizations, as reported by five studies. Additionally, support from community health workers and referrals from friends and family were each cited by four studies.

Discussion

In this systematic review, we considered the frequency of citations found in the included studies to determine the main enablers and barriers to participation in biomedical research on NTDs. Monetary benefits or other rewards, personal health benefits, community engagement strategies and sensitization, and comprehensive information were identified as the main enablers, while lack of knowledge, and mistrust were identified as the main barriers.

After analyzing the literature on willingness to participate (WTP) in research, we have concluded that factors such as personal health benefits and altruism are commonly cited regardless of the disease being studied [2931]. However, we have observed that depending on the field in which WTP research is being conducted, some barriers and enablers are more frequently reported. This suggests that the challenges in recruiting participants have specificities related to the context in which the research is carried out, such as the socioeconomic conditions and the disease being studied [2938].

In a systematic review conducted by Browne et al. [15] on WTP in research involving human beings in low- and middle-income countries, a set of barriers and enablers for participation in research were identified [15]. While eleven of those barriers and enablers were not found in the studies included in our review, eleven barriers and nine enablers present in our review were not cited in the article of Browne et al [15]. Those new factors favoring participation exclusively found in our review are the following community strategies of engagement and sensibilization, comprehensive information for the study population, expenditure refund, integrate local community members in the research planning and execution, positive previous experience with researches, respect for the local values, support from local leadership, to ensure time enough for discussion between community members and relatives, and written and oral informed consent form [15]. Those new factors serving as barriers exclusively found in our review are the following: communication problems between researchers and participants, disagreement with research requirement, false stories, gender questions, local political conflicts, long studies, mistaken information about previous researches, negative influence from media, religious beliefs, the large interval between sensibilization and recruitment, and “therapeutic misconception”.

This divergence between our founding and the founding of Browne et al [15] suggests that although the socioeconomic context is relevant, it alone does not fully explain the barriers and facilitators for participation in research, in such a way that intrinsic factors related to NTDs, such as the natural history of the disease, risk factors, and the epidemiological chain, can generate specific facilitators and barriers for this group of diseases

The impact of multiple factors on WTP in research can be exemplified by the role of stigmatization in the decision not to participate in a podoconiosis genetic study [23]. Without a study on WTP in research in the context of podoconiosis, it would not have been revealed that being identified as a subject of a genetic study of podoconiosis causes social disapproval and stigmatization for potential participants, leading to low recruitment rates. This illustrates the role of cultural aspects and the contribution of specificities of the disease covered by the study of WTP in research.

Our review highlighted the crucial role of social support in individuals’ choice to participate in a study. Therefore, strategies such as community engagement are useful for improving recruitment rates. We also identified that lack of clarity in information has a negative impact on WTP in research. Thus, it would be important to expand the use of social media, such as journals, social networks, radio, and television, to share necessary information about the research for potential participants. In addition, we recommend the following types of recruitment interventions in the context of research on NTDS: contact with community leaders and organizations with support from community health workers, face-to-face in the community setting, and recommendations from friends and family.

In conclusion, this systematic review presents recommendations that can be applied to improve adherence in biomedical research on Neglected Tropical Diseases. A study conducted outside the context of NTDs showed that previous qualitative investigations of barriers and enablers of the recruitment process led to better recruitment rates in subsequent biomedical research [3738]. Thus, applying the knowledge present in our review could change the probable outcome of a low recruitment rate in biomedical research carried out in the context of NTDs.

We identified some potential limitations of this systematic review. Despite the wide search conducted in the literature, only eleven studies met the inclusion criteria of our systematic review. Out of the 20 diseases classified as NTDs by WHO, we found studies on only five: dengue, mycetoma, podoconiosis, schistosomiasis, and onchocerciasis. This shows that the theme of WTP in research on NTDs is itself neglected, making it difficult to create and adopt strategies that avoid insufficient recruitment of subjects for research.

On the other hand, this systematic review has several strong points. The steps of selection, assessment, and extraction of the data were done independently by at least two authors. This reduces the chance of introducing bias, such as selection bias. Furthermore, we conducted a wide search in the literature with the assistance of a specialist (MMS). In general, this systematic review closely fulfills the methodology criterion of a systematic review, has been published previously in the protocol, and follows the recommendations for conducting a systematic review established by PRISMA and the Joanna Briggs Institute.

Supporting information

S1 Appendix. Protocol registered in PROSPERO.

(PDF)

pntd.0011996.s001.pdf (171.1KB, pdf)
S2 Appendix. PRISMA checklist.

(DOCX)

pntd.0011996.s002.docx (30.6KB, docx)
S3 Appendix. Search strategies.

(DOCX)

pntd.0011996.s003.docx (21.3KB, docx)

Acknowledgments

We thank Jorgana Soares, Luciano Kalabric, Rita Fernandes, and Ronald Blanton for the final review of the manuscript. We also express our gratitude to Caroline Vieira and Thiago Cerqueira for their valuable comments, which contributed to the development of Fig 2.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was funded by National Institutes of Health (NIH), Grant/Award Numbers: R01 AI121330 to MGR, FAPESB-PNX0001/2015 to MGR for the submitted work, and partially supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq (Proc. Proc. 306464/2016-0 and 423833/2018-9) to VRS. VRS is currently receiving a scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Fam E, Ferrante JM. Lessons learned recruiting minority participants for research in urban community health centers. J Natl Med Assoc. 2018;110: 44–52. doi: 10.1016/j.jnma.2017.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Froelicher ES, Lorig K. Who cares about recruitment anyway? Patient Educ Couns. 2002;48: 97. doi: 10.1016/s0738-3991(02)00168-4 [DOI] [PubMed] [Google Scholar]
  • 3.McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7: 9. doi: 10.1186/1745-6215-7-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrøm M, Johansen M, et al. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013;3: e002360. doi: 10.1136/bmjopen-2012-002360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mfutso-Bengo J, Masiye F, Molyneux M, Ndebele P, Chilungo A. Why do people refuse to take part in biomedical research studies? Evidence from a resource-poor area. Malawi Med J. 2008;20: 57–63. doi: 10.4314/mmj.v20i2.10958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brannon EE, Kuhl ES, Boles RE, Aylward BS, Benoit Ratcliff M, Valenzuela JM, et al. Strategies for recruitment and retention of families from low-income, ethnic minority backgrounds in a longitudinal study of caregiver feeding and child weight. child heal care. 2013;42: 198–213. doi: 10.1080/02739615.2013.816590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104: e16–e31. doi: 10.2105/AJPH.2013.301706 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Newington L, Metcalfe A. Factors influencing recruitment to research: qualitative study of the experiences and perceptions of research teams. BMC Med Res Methodol. 2014;14: 10. doi: 10.1186/1471-2288-14-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.World Health Organization. Neglected tropical diseases. Available at: https://www.paho.org/en/campaigns/world-neglected-tropical-diseases-day-2022. Accessed 21 February 2024
  • 10.World Health Organization. Neglected tropical diseases. Available at: https://www.who.int/news-room/questions-and-answers/item/neglected-tropical-diseases#:~:text=NTDs%20include%3A%20Buruli%20ulcer%3B%20Chagas,rabies%3B%20scabies%20and%20other%20ectoparasitoses%3B. Accessed 21 February 2024
  • 11.Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004;189: 930–937. doi: 10.1086/381709 [DOI] [PubMed] [Google Scholar]
  • 12.Uniting to Combat Neglected Tropical Diseases. Resources [Internet]. 2023. [cited 20 Dec 2023]. Available from: https://unitingtocombatntds.org/en/neglected-tropical-diseases/resources/
  • 13.Ackley C, Elsheikh M, Zaman S. Scoping review of neglected tropical disease interventions and health promotion: A framework for successful NTD interventions as evidenced by the literature. PLoS Negl Trop Dis. 2021;15: e0009278. doi: 10.1371/journal.pntd.0009278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Reed SL, McKerrow JH. Why funding for neglected tropical diseases should be a global priority. Clin Infect Dis. 2018;67: 323–326. doi: 10.1093/cid/ciy349 [DOI] [PubMed] [Google Scholar]
  • 15.Browne JL, Rees CO, van Delden JJM, Agyepong I, Grobbee DE, Edwin A, et al. The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review. Trop Med Int Heal. 2019;24: 264–279. doi: 10.1111/tmi.13195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.UyBico SJ, Pavel S, Gross CP. Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med. 2007;22: 852–863. doi: 10.1007/s11606-007-0126-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Guerra CLP, Rodríguez-Acosta R, Soto-Gómez E, Zielinski-Gutierrez E, Peña-Orellana M, Santiago L, et al. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico. Hum Vaccin Immunother. 2012;8: 905–915. doi: 10.4161/hv.20056 [DOI] [PubMed] [Google Scholar]
  • 18.Harapan H, Anwar S, Bustaman A, Radiansyah A, Angraini P, Fasli R, et al. Community willingness to participate in a dengue study in Aceh Province, Indonesia. PLoS One. 2016;11: e0159139. doi: 10.1371/journal.pone.0159139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gebresilase TT, Deresse Z, Tsegay G, Tessema TS, Aseffa A, Davey G, et al. Rapid ethical appraisal: a tool to design a contextualized consent process for a genetic study of podoconiosis in Ethiopia. Wellcome Open Res. 2017;2: 99. doi: 10.12688/wellcomeopenres.12613.1 [DOI] [Google Scholar]
  • 20.Akun PR, Anguzu R, Ogwang R, Oryema JJI, Ningwa A, Idro R. Implementation of a community engagement program in the pathogenesis and treatment of nodding syndrome study in Uganda. Poster session presented at: 10th European Congress on Tropical Medicine and International health; 2017 Oct 16–20; Antwerp, Belgium. Trop Med Int Health. 2017;22 (suppl.1): 343. doi: 10.1111/(ISSN)1365-3156 [DOI] [Google Scholar]
  • 21.Negussie H, Addissie T, Addissie A, Davey G. Preparing for and executing a randomised controlled trial of podoconiosis treatment in northern Ethiopia: the utility of rapid ethical assessment. Lammie PJ, organizador. PLoS Negl Trop Dis. 2016;10: e0004531. doi: 10.1371/journal.pntd.0004531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sanya RE, Tumwesige E, Elliott AM, Seeley J. Perceptions about interventions to control schistosomiasis among the Lake Victoria Island communities of Koome, Uganda. PLoS Negl Trop Dis. 2017;11. doi: 10.1371/journal.pntd.0005982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tekola F, Bull S, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, et al. Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: a qualitative study. BMC Med Ethics. 2009;10: 13. doi: 10.1186/1472-6939-10-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tekola F, Bull SJ, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, et al. Tailoring consent to context: designing an appropriate consent process for a biomedical study in a low income setting. PLoS Negl Trop Dis. 2009;3: e482. doi: 10.1371/journal.pntd.0000482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Negash M, Chanyalew M, T Gebresilase T, Sintayehu B, Anteye T, Aseffa A, et al. Rapid ethical appraisal of stakeholder views on research prior to undertaking immunopathogenesis studies on podoconiosis in northeast Ethiopia during a period of social instability. Trans R Soc Trop Med Hyg. 2021;115: 1026–1038. doi: 10.1093/trstmh/trab003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Omer RF, Ahmed ES, Ali BM, Alhaj HE, Bakhiet SM, Mohamed ESW, et al. The challenges of recruitment in clinical trials in developing countries: the Mycetoma Research Centre experience. Trans R Soc Trop Med Hyg. 2021;115: 397–405. doi: 10.1093/trstmh/traa165 [DOI] [PubMed] [Google Scholar]
  • 27.Critical Appraisal Skills Programme. Critical appraisal checklists [Internet]. Oxford; 2021. [cited 20 Dec 2023]. Available from: https://casp-uk.net/casp-tools-checklists/
  • 28.Joanna Briggs Institute. Critical appraisal tools [Internet]. Adelaide [Australia]; 2020. [cited 20 Dec 2023]. Available: https://jbi.global/critical-appraisal-tools
  • 29.Paré Toe L, Ravinetto RM, Dierickx S, Gryseels C, Tinto H, Rouamba N, et al. Could the decision of trial participation precede the informed consent process? evidence from Burkina Faso. Choonara I, organizador. PLoS One. 2013;8: e80800. doi: 10.1371/journal.pone.0080800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mahomed H, Shea J, Kafaar F, Hawkridge T, Hanekom WA, Hussey GD. Are adolescents ready for tuberculosis vaccine trials? Vaccine. 2008;26: 4725–4730. doi: 10.1016/j.vaccine.2008.06.088 [DOI] [PubMed] [Google Scholar]
  • 31.Kufa T, Chihota V, Charalambous S, Verver S, Churchyard G. Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults. Public Health Action. 2013;3: 31–37. doi: 10.5588/pha.12.0102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Okall DO, Ondenge K, Nyambura M, Otieno FO, Hardnett F, Turner K, et al. Men who have sex with men in Kisumu, Kenya: comfort in accessing health services and willingness to participate in hiv prevention studies. J Homosex. 2014;61: 1712–1726. doi: 10.1080/00918369.2014.951261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Newman PA, Chakrapani V, Weaver J, Shunmugam M, Rubincam C. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India. Vaccine. 2014;32: 5854–5861. doi: 10.1016/j.vaccine.2014.08.043 [DOI] [PubMed] [Google Scholar]
  • 34.Li Q, Luo F, Zhou Z, Li S, Liu Y, Li D, et al. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men. Vaccine. 2010;28: 4638–4643. doi: 10.1016/j.vaccine.2010.04.073 [DOI] [PubMed] [Google Scholar]
  • 35.Jenkins RA. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sex Transm Infect. 2000;76: 386–392. doi: 10.1136/sti.76.5.386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Meque I, Dubé K, Bierhuizen L, Zango A, Veldhuijzen N, Cumbe F, et al. Willingness to participate in future HIV prevention trials in Beira, Mozambique. African J AIDS Res. 2014;13: 393–398. doi: 10.2989/16085906.2014.985239 [DOI] [PubMed] [Google Scholar]
  • 37.Donovan J, Little P, Mills N, Smith M, Brindle L, Jacoby A, et al. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ. 2002;325: 766–770. doi: 10.1136/bmj.325.7367.766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Almeida CH, Marques R de C, Reis DC, Melo JM do C, Diemert D, Gazzinelli MF. A pesquisa científica na saúde: uma análise sobre a participação de populações vulneráveis. Texto Context—Enferm. 2010;19: 104–111. doi: 10.1590/S0104-07072010000100012 [DOI] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011996.r001

Decision Letter 0

Dileepa Ediriweera, Felix Bongomin

20 Dec 2023

Dear Dr Reis,

Thank you very much for submitting your manuscript "Factors related to willingness to participate in biomedical research on neglected tropical diseases: A Systematic Review" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Felix Bongomin, MB ChB, MSc, MMed, FECMM

Academic Editor

PLOS Neglected Tropical Diseases

Dileepa Ediriweera

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The methods for this systematic review are sound and are in accordance with best practice (PRISMA and the PRISMA-S checklist). The authors need to be specific in the abstract and in the Search strategy and selection criteria section about which platforms they searched the database Embase on, and state that they searched the WHO Global Index Medicus, as well as which version of the Web of Science they searched (All Databases or the Core Collection?). This information needs to be provided consistently in the abstract and in the main text.

One typo: the abstract needs to be corrected to "1470 from the databases".

Thank you very much for including the PROSPERO protocol, the PRISMA checklist, and the reproducible search strategies in the Supporting Information, in line with best practice.

Which software did you use to screen the papers? Mendeley?

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: I have no comments to make on the results. The results are well presented and they are very clear. Thank you.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusions are presented in the DISCUSSION section. The conclusions are clearly supported by the data. The authors discuss how the findings could contribute to improve recruitment rates in future, thus addressing the public health relevance of their review.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: In terms of editorial comments:

The authors need to check all of the references to correct the entries which are missing author names, or which have errant details. The citation style is inconsistent. Every reference needs to be checked and corrected.

Could the authors present their recommendations about ways to improve recruitment rates in visual form to make the paper more of a pleasure to read and improve the accessibility of their findings?

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This systematic review is timely and unique in the literature, filling a niche and contributing to the overall literature about research participation and the state of research on NTDs overall. Thank you.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Elinor Harriss

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info:doi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011996.r003

Decision Letter 1

Dileepa Ediriweera, Felix Bongomin

14 Feb 2024

Dear Dr Reis,

We are pleased to inform you that your manuscript 'Factors related to willingness to participate in biomedical research on neglected tropical diseases: A Systematic Review' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Felix Bongomin, MB ChB, MSc, MMed, FECMM

Academic Editor

PLOS Neglected Tropical Diseases

Dileepa Ediriweera

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011996.r004

Acceptance letter

Dileepa Ediriweera, Felix Bongomin

5 Mar 2024

Dear Dr Reis,

We are delighted to inform you that your manuscript, "Factors related to willingness to participate in biomedical research on neglected tropical diseases: a systematic review," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Protocol registered in PROSPERO.

    (PDF)

    pntd.0011996.s001.pdf (171.1KB, pdf)
    S2 Appendix. PRISMA checklist.

    (DOCX)

    pntd.0011996.s002.docx (30.6KB, docx)
    S3 Appendix. Search strategies.

    (DOCX)

    pntd.0011996.s003.docx (21.3KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pntd.0011996.s004.docx (19.8KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES